Skip to main content
. 2020 Nov 23;18:371. doi: 10.1186/s12955-020-01551-5

Table 3.

Patient characteristics

Patient
Interview 1 Interview 2 Interview 3
MITOS stage n % n % n %
 0 21 75.0 18 64.3 13 46.4
 1 6 21.4 8 28.6 11 39.3
 2 2 7.1 2 7.1
 3
 Not available 1 3.6 2 7.1
Cognition (ECAS)
 Normal 21 75.0 20 71.4 18 64.3
 Non-normal 6 21.4 7 25.0 9 32.1
 Not Available 1 3.6 1 3.6 1 3.6
Behaviour (BBI)
 Normal 18 64.3 16 57.1 15 53.6
 Non-normal 8 28.6 10 35.7 11 39.3
 Not Available 2 7.1 2 7.1 2 7.1
HADS DISTRESS
 Mean 10.8 12.3 11.4
 Standard deviation 7.0 6.6 7.9
 Median 9.5 10.5 10.5
 Range (0–27) (3–26) (0–30)
 % Above Cut-off 11 39% 12 43% 13 46%
SeiQoL Index (SIS)
 Mean 77.5 76.3 77.7
 Standard deviation 14.9 19.1 13.1
 Median 83.1 77.1 80.6
 IQR (68.72–86.99) (70.56–90.66) (68.02–89.04)
 Range (23.68–95.8) (6.75–96.99) (44.59–95.38)

MITOS Milano-Torino Staging

ECAS Edinburgh Cognitive and Behavioural ALS Screen

BBI Beaumont Behavioural Inventory

HADS Hospital Anxiety and Depression Scale

SeiQoL Schedule for Individual Quality of Life